These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4292024)

  • 1. The effect of conjugated estrogens and estriol succinate on fibrinolysis. A clinical correlation in patients with uterine bleeding.
    Villadolid LS; Romero RC; Egay L; Millora A; Negre M; Abundo C; Ongjoco G; Llamas S; Santos AA
    J Jpn Obstet Gynecol Soc; 1966 Apr; 13(2):131-8. PubMed ID: 4292024
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of conjugated estrogens and estriol succinate on fibrinolysis: a clinical correlation in patients with uterine bleeding.
    Villadolid LS; Romero RC; Egay LM; Millora A; Negre M; Abundo C; Ongjoco G; Llamas S; Santos AA
    Acta Med Philipp; 1965; 2(2):82-7. PubMed ID: 4285669
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of premarin, conjugated estrogens-equine to control. Functional uterine bleeding and the urinary estrogen metabolism after administration.
    Hamada H
    Bull Osaka Med Sch; 1971 Oct; 17(2):130-42. PubMed ID: 4347399
    [No Abstract]   [Full Text] [Related]  

  • 4. The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina.
    Widholm O; Vartiainen E
    Ann Chir Gynaecol Fenn; 1974; 63(3):186-90. PubMed ID: 4370430
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
    Ambrus JL; Schimert G; Lajos TZ; Ambrus CM; Mink IB; Lassman HB; Moore RH; Melzer J
    J Med; 1971; 2(2):65-81. PubMed ID: 4329735
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study.
    DeVore GR; Owens O; Kase N
    Obstet Gynecol; 1982 Mar; 59(3):285-91. PubMed ID: 6281704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effect of estriol and equine conjugated estrogens on the uterus and the vagina.
    Phillips A; Hahn DW; McGuire JL
    Maturitas; 1984 Mar; 5(3):147-52. PubMed ID: 6328221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women.
    Notelovitz M; Kitchens CS; Ware MD
    Obstet Gynecol; 1984 May; 63(5):621-5. PubMed ID: 6326012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of climacteric disorders. Clinical results].
    Kölblová V; Laitl J; Horský J
    Munch Med Wochenschr; 1972 Nov; 114(46):2039-40. PubMed ID: 4345883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medification of the hypertensive effects of catecholamines and of Val-5-angiotensin II in the rat, by the use of several estrogens].
    Limet R; Cession G; Cession-Fossion A
    C R Seances Soc Biol Fil; 1967 Nov; 161(5):1159-61. PubMed ID: 4294564
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of premarin tablets and intravenous injection of premarin on functional uterine bleeding].
    Igarashi M; Shiozaki T; Kamioka J; Sato S; Fujima Y
    Horumon To Rinsho; 1970 Jan; 18(1):75-8. PubMed ID: 4313597
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of estrogens on blood clotting and plasmin systems.
    Nagayama M; Maki M; Kikuchi I; Kanbe K; Sasaki K; Sasaki K
    Tohoku J Exp Med; 1965 Aug; 86(3):219-29. PubMed ID: 4287508
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial treatment of dysfunctional uterine bleeding with estrogen--progestin combination.
    Mansuwan K
    J Med Assoc Thai; 1980 Jan; 63(1):6-10. PubMed ID: 7359057
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful medical management of post-hysteroscopic metroplasty bleeding with intravenous estrogen therapy: a report of two cases and review of the literature.
    Scoccia B; Demir H; Elter K; Scommegna A
    J Minim Invasive Gynecol; 2009; 16(5):639-42. PubMed ID: 19835811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of hemostasis in heart surgery].
    Kraft-Kinz J; Eide M; Friehs G; Koch G
    Thoraxchir Vask Chir; 1969 Apr; 17(2):157-66. PubMed ID: 4321144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of functional uterine hemorrhages with epsilon-aminocapric acid ("EAC", Berlin-Chemie)].
    Linz O
    Dtsch Gesundheitsw; 1967 Sep; 22(35):1652-6. PubMed ID: 5614051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.